drugset / Trial / NCT00076323

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

NCT00076323

Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.

Timeline

Start
2003-12
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Primaquine Small molecule

Indications